Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging

Stem Cells and Development

Volumn 20, Issue 1, 2011, Pages 53-66

  Halfon, Svetlana ^a   Abramov, Natalie ^a   Grinblat, Borislava ^a   Ginis, Irene ^a  

^a Teva Pharmaceutical Industries   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA11 INTEGRIN; BETA1 INTEGRIN; CD146 ANTIGEN; CD9 ANTIGEN; CELL MARKER; ENDOGLIN; HERMES ANTIGEN; INTEGRIN; INTERSTITIAL COLLAGENASE; SOMATOMEDIN B; STROMELYSIN; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; CRYOPRESERVATION; DOWN REGULATION; FIBROBLAST; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG FIBROBLAST; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; UPREGULATION;

ADULT; ANIMALS; BIOLOGICAL MARKERS; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DOWN-REGULATION; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 78650966081     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0040     Document Type: Article

References (69)

1. Izadpanah R, D Kausha, C Kriedt, F Tsien, B Patel, J Dufour and BA Bunnell. (2008). Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68:4229-4238.
2. Bonab MM, K Alimoghaddam, F Talebian, SH Ghaffari, A Ghavamzadeh and B Nikbin. (2006). Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:14.
3. Rubio D, J Garcia-Castro, MC Martin, R de la Fuente, JC Cigudosa, AC Lloyd and A Bernad. (2005). Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039.
4. Miura M, Y Miura, HM Padilla-Nash, AA Molinolo, B Fu, V Patel, BM Seo, W Sonoyama, JJ Zheng, CC Baker, W Chen, T Ried and S Shi. (2006). Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24:1095-1103.
5. Zhou YF, M Bosch-Marce, H Okuyama, B Krishnamachary, H Kimura, L Zhang, DL Huso and GL Semenza. (2006). Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res 66:10849-10854.
6. Røsland GV, A Svendsen, A Torsvik, E Sobala, E McCormack, H Immervoll, J Mysliwietz, JC Tonn, R Goldbrunner, PE Lønning, R Bjerkvig and C Schichor. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69:5331-5339.
7. Ratajczak MZ, M Kucia, M Majka, R Reca and J Ratajczak. (2004). Heterogeneous populations of bone marrow stem cells-are we spotting on the same cells from the different angles? Folia Histochem Cytobiol 42:139-146.
8. Wagner W and AD Ho. (2007). Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev 3:239-248.
9. Ho AD, W Wagner and W Franke. (2008). Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10: 320-330.
10. Colter DC, I Sekiya, and DJ Prockop. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 98:7841-7845. (Pubitemid 32642648)
11. Prockop DJ and SD Olson. (2007). Clinical trials with adult stem=progenitor cells for tissue repair: lets not overlook some essential precautions. Blood 109:3147-3151.
12. Colter DC, R Class, CM DiGirolamo and DJ Prockop. (2000). Rapid expansion of recycling stem cells in cultures of plasticadherent cells from human bone marrow. Proc Natl Acad Sci U S A 97:3213-3218.
13. Johnstone B, TM Hering, AI Caplan, VM Goldberg and JU Yoo. (1998). In vitro chondrogenesis of bone marrowderived mesenchymal progenitor cells. Exp Cell Res.238: 265-272.
14. Pfaffla MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
15. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
16. Leomil Coelho LF, BE Mota, PC Sales, JT Marques, JG de Oliveira, CA Bonjardim, PC Peregrino Ferreira and EG Kroon. (2006). Integrin alpha 11 is a novel type I interferon stimulated gene. Cytokine 33:352-361.
17. Sorrentino A, M Ferracin, G Castelli, M Biffoni, G Tomaselli, M Baiocchi, A Fatica, M Negrini, C Peschle and M Valtieri. (2008). Isolation and characterization of CD146 multipotent mesenchymal stromal cells. Exp Hematol 36:1035-1046.
18. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, FC Marini, RJ Deans, DS Krause and A Keating. (2005). Clarification of the nomenclature for MSC. The International Society for Cellular Therapy position statement. Cytotherapy 7:393-395.
19. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
20. Ishii M, C Koike, A Igarashi, K Yamanaka, H Pan, Y Higashi, H Kawaguchi, M Sugiyama, N Kamata, T Iwata, T Matsubara, K Nakamura, H Kurihara, K Tsuji and Y Kato. (2005). Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Commun 24:297-303.
21. Bae S, JH Ahn, CW Park, HK Son, KS Kim, NK Lim, CJ Jeon and H Kim. (2009). Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res 335:565-573.
22. Hee CK, MA Jonikas and SB Nicoll. (2006). Influence of three-dimensional scaffold on the expression of osteogenic differentiation markers by human dermal fibroblasts. Biomaterials 27:875-884.
23. Lysy PA, F Smets, C Sibille, M Najimi and EM Sokal. (2007). Human skin fibroblasts: from mesodermal to heptatocytelike differentiation. Hepatol 46:1574-1585.
24. Lorenz K, M Sicker, E Schmelzer, T Rupf, J Salvetter, M Schulz-Siegmund and A Bader. (2008). Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 11:925-932.
25. Sommar P, S Pettersson, C Ness, H Johnson, G Kratz and JP Junker. (2010). Engineering three-dimensional cartilage-and bone-like tissues using human dermal fibroblasts and macroporous gelatine microcarriers. J Plast Reconstr Aesthet Surg 63:1036-1046.
26. Junker JP, P Sommar, M Skog, H Johnson and G Kratz. (2010). Adipogenic, chondrogenic and osteogenic differentiation of clonally derived human dermal fibroblasts. Cells Tissues Organs 191:105-118.
27. Karlsson LK, JP Junker, M Grenegård and G Kratz. (2009). Human dermal fibroblasts: a potential cell source for endothelialization of vascular grafts. Ann Vasc Surg 23:663-674.
28. Haniffa MA, XN Wang, U Holtick, M Rae, JD Isaacs, AM Dickinson, CM Hilkens and MP Collin. (2007). Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 179:1595-1604.
29. Haniffa MA, MP Collin, CD Buckley and F Dazzi. (2009). Mesenchymal stem cells: the fibroblasts new clothes? Haematologica 94:258-263.
30. Swart GW. (2002). Activated leukocyte cell adhesion molecule (CD166=ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur J Cell Biol 81:313-321.
31. Hemler ME. (2003). Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19:397-422.
32. Morrish DW, AR Shaw, J Seehafer, D Bhardwaj and MT Paras. (1991). Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen. In Vitro Cell Dev Biol 27A:303-306.
33. Oritani K, X Wu, K Medina, J Hudson, K Miyake, JM Gimble, SA Burstein, and PW Kincade. (1996). Antibody ligation of CD9 modifies production of myeloid cells in longterm cultures. Blood 87:2252-2261.
34. Aoyama K, K Oritani, T Yokota, J Ishikawa, T Nishiura, K Miyake, Y Kanakura, Y Tomiyama, PW Kincade, and Y Matsuzawa. (1999). Stromal cell CD9 regulates differentiation of hematopoietic stem=progenitor cells. Blood 93:2586-2594.
35. Whitham SE, G Murphy, P Angel, HJ Rahmsdorf, BJ Smith, A Lyons, TJ Harris, JJ Reynolds, P Herrlich and AJ Docherty. (1986). Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J 240:913-916.
36. Formstone CJ, PJ Byrd, HJ Ambrose, JH Riley, D Hernandez, CM McConville and AM Taylor. (1993). The order and orientation of a cluster of metalloproteinase genes, stromelysin 2, collagenase, and stromelysin, together with D11S385, on chromosome 11q22-q23. Genomics 16:289-291.
37. Saarialho-Kere UK, AP Pentland, H Birkedal-Hansen, WC Parks and HG Welgus. (1994). Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 94:79-88.
38. Sellers A and G Murphy. (1981). Collagenolytic enzymes and their naturally occurring inhibitors. Int Rev Connect Tissue Res 9:151-190.
39. Saus J, S Quinones, Y Otani, H Nagase, ED Harris and M Kurkinen. (1988). The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem 15:6742-6745.
40. Arakaki PA, MR Marques and MC Santos. (2009). MMP-1 polymorphism and its relationship to pathological processes. J Biosci 34:313-320.
41. Gullberg D, T Velling, G Sjöberg and T Sejersen. (1995). Upregulation of a novel integrin alpha-chain (alpha mt) on human fetal myotubes. Dev Dyn 204:57-65.
42. Velling T, M Kusche-Gullberg, T Sejersen and D Gullberg. (1999). cDNA cloning and chromosomal localization of human alpha(11) integrin. A collagen-binding, I domaincontaining, beta(1)-associated integrin alpha-chain present in muscle tissues. J Biol Chem 274:25735-25742.
43. Lehnert K, J Ni, E Leung, SM Gough, A Weaver, WP Yao, D Liu, SX Wang, CM Morris and GW Krissansen. (1999). Cloning, sequence analysis, and chromosomal localization of the novel human integrin alpha11 subunit (ITGA11). Genomics 60:179-187.
44. Tiger CF, F Fougerousse, G Grundström, T Velling and D Gullberg. (2001). alpha11beta1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev Biol 237:116-129.
45. Zhang WM, J Kapyla, JS Puranen, CG Knight, CF Tiger, OT Pentikainen, MS Johnson, RW Farndale, J Heino and D Gullberg. (2003). alpha 11beta 1 integrin recognizes the GFOGER sequence in interstitial collagens. J Biol Chem 278:7270-7277.
46. Wang KK, N Liu, N Radulovich, DA Wigle, MR Johnston, FA Shepherd, MD Minden and MS Tsao. (2002). Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene 21:7598-7604.
47. Zhu CQ, SN Popova, ER Brown, D Barsyte-Lovejoy, R Navab, W Shih, M Li, M Lu, I Jurisica, LZ Penn, D Gullberg and MS Tsao. (2007). Integrin alpha 11 regulates IGF-2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells. Proc Natl Acad Sci U S A 104:11754-11759.
48. Wilson EM and P Rotwein. (2006). Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281:29962-29971.
49. Conover CA. (2008). Insulin-like growth factor-binding proteins and bone metabolism. Am J Physiol Endocrinol Metab 294:E10-E14.
50. Chao W and PA DAmore. (2008). IGF-2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 19:111-120.
51. Simmons PJ, B Masinovsky, BM Longenecker, R Berenson, B Torok-Storb, and WM Gallatin. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80:388-395.
52. Liu F, Y Akiyama, S Tai, K Maruyama, Y Kawaguchi, K Muramatsu and KJ Yamaguchi. (2008). Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells. Bone Miner Metab 26:312-320.
53. Böcker W, D Docheva, WC Prall, V Egea, E Pappou, O Rossmann, C Popov, W Mutschler, C Ries, and M Schieker. (2008). IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med 86:1183-1192.
54. Fu X, B Han, S Cai, Y Lei, T Sun, and Z Sheng. (2009). Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing. Wound Repair Regen 17:185-189.
55. Segers VF, I Van Riet, LJ Andries, K Lemmens, MJ Demolder, AJ De Becker, MM Kockx, and GW De Keulenaer. (2006). Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. AmJ Physiol Heart Circ Physiol 290:H1370-H1377.
56. Smith AN, E Willis, VT Chan, LA Muffley, FF Isik, NS Gibran, and AM Hocking. (2010). Mesenchymal stem cells induce dermal fibroblast responses to injury. Exp Cell Res 316:48-54.
57. Ren G, X Zhao, L Zhang, J Zhang, A LHuillier, W Ling, AI Roberts, AD Le, S Shi, C Shao, and Y Shi. (2010). Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184:2321-2328.
58. Miyazaki T, Y Kitagawa, K Toriyama, M Kobori and S Torii. (2005). Isolation of two human fibroblastic cell populations with multiple but distinct potential of mesenchymal differentiation by ceiling culture of mature fat cells from subcutaneous adipose tissue. Differentiation 73:69-78.
59. Gronthos S, AC Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis and PJ Simmons. (2003). Molecular and cellular characterization of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
60. Gronthos S and AC Zannettino. (2008). A method to isolate and purify human bone marrow stromal stem cells. Methods Mol Biol 449:45-57.
61. Fukiage K, T Aoyama, KR Shibata, S Otsuka, M Furu, Y Kohno, K Ito, Y Jin, S Fujita, S Fujibayashi, M Neo, T Nakayama, T Nakamura and J Toguchida. (2008). Expression of vascular cell adhesion molecule-1 indicates the differentiation potential of human bone marrow stromal cells. Biochem Biophys Res Commun 365:406-412.
62. Honczarenko M, Y Le, M Swierkowski, I Ghiran, AM Glodek and LE Silberstein. (2006). Human bone marrow stromal cells express a distinct set of biologically functional hemokine receptors. Stem Cells 24:1030-1041.
63. Majumdar MK,M Keane-Moore, D Buyaner,WB Hardy, MA Moorman, KR McIntosh and JD Mosca. (2003). Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10:228-241.
64. Schieker M, C Pautke, F Haasters, J Schieker, D Docheva, W Böcker, H Guelkan, P Neth, M Jochum and W Mutschler. (2007). Human mesenchymal stem cells at the single-cell level: simultaneous seven-colour immunofluorescence. J Anat 210:592-599.
65. Xu J, W Wang, Y Kapila, J Lotz and S Kapila. (2009). Multiple differentiation capacity of STRO-1=CD146PDL mesenchymal progenitor cells. Stem Cells Dev 18:487-496.
66. Covas DT, RA Panepucci, AM Fontes, WA Silva, MD Orellana, MC Freitas, L Neder, AR Santos, LC Peres, MC Jamur and MA Zago. (2008). Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 perivascular cells and fibroblasts. Exp Hematol 36: 642-654.
67. Le Blanc K, C Tammik, K Rosendahl, E Zetterberg, and O Ringdén. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896.
68. Mitchell JB, K McIntosh, S Zvonic, S Garrett, ZE Floyd, A Kloster, Y Di Halvorsen, RW Storms, B Goh, G Kilroy, X Wu, and JM Gimble.(2006). Immunophenotype of human adiposederived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24:376-385.
69. Kern S, H Eichler, J Stoeve, H Klüter, and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.